NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
Estimated value
—
Awarded value
£201.7m
Awarded 14 Jun 2026
Suppliers
27
6 SME
Lots
2
2 awarded
Published
23 Jun 2026
Award 1· 25 suppliers
Awarded 14 Jun 2026 · Contract period 31 Aug 2026 — 31 Aug 2028
Award value
£166.3m
Award 2· 2 suppliers
Awarded 14 Jun 2026 · Contract period 31 Aug 2026 — 31 Aug 2027
Award value
£35.3m